(Q39093634)

English

Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014.

scientific article published on 21 October 2016

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Long-term Impact of a "3 + 0" Schedule for 7- and 13-Valent Pneumococcal Conjugate Vaccines on Invasive Pneumococcal Disease in Australia, 2002-2014. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

0 references

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Christopher Blyth

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Peter B. McIntyre

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

6

object named as

Vicki Krause

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Sanjay Jayasinghe

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Clayton Chiu

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Cindy Toms

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

0 references

publication date

21 October 2016

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

64

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

175-183

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Effect of vaccines on bacterial meningitis worldwide

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Long term population impact of seven-valent pneumococcal conjugate vaccine with a "3+0″ schedule-How do "2+1″ and "3+1″ schedules compare?

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: Uncertain herd impact on pneumonia critical.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

The impact of pneumococcal conjugate vaccine on rates of myringotomy with ventilation tube insertion in Australia.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Comparing pneumococcal conjugate vaccine schedules based on 3 and 2 primary doses: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Optimizing the use of pneumococcal conjugate vaccine globally

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Ebola: the real lessons from HIV scale-up.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on vaccine-type nasopharyngeal carriage

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Serotype dynamics of invasive pneumococcal disease post-PCV7 and pre-PCV13 introduction in North East England

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Epidemiological differences among pneumococcal serotypes

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Effectiveness of the new serotypes in the 13-valent pneumococcal conjugate vaccine

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Pneumococcal serotypes and mortality following invasive pneumococcal disease: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged ≥50 years with community-acquired pneumonia

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Effects of vaccination on invasive pneumococcal disease in South Africa

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Trends in Asymptomatic Nasopharyngeal Colonization With Streptococcus pneumoniae After Introduction of the 13-valent Pneumococcal Conjugate Vaccine in Calgary, Canada

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIW720

21 January 2018

Identifiers

10.1093/CID/CIW720

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27986682%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39093634&oldid=1896768907"